ID   UBE2N_HUMAN             Reviewed;         152 AA.
AC   P61088; Q16781; Q53Y81;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2004, sequence version 1.
DT   10-MAY-2017, entry version 163.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 N;
DE            EC=2.3.2.23 {ECO:0000269|PubMed:20061386};
DE   AltName: Full=Bendless-like ubiquitin-conjugating enzyme;
DE   AltName: Full=E2 ubiquitin-conjugating enzyme N;
DE   AltName: Full=Ubc13;
DE   AltName: Full=UbcH13;
DE   AltName: Full=Ubiquitin carrier protein N;
DE   AltName: Full=Ubiquitin-protein ligase N;
GN   Name=UBE2N; Synonyms=BLU;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8902611; DOI=10.1093/oxfordjournals.jbchem.a021440;
RA   Yamaguchi T., Kim N.-S., Sekine S., Seino H., Osaka F., Yamao F.,
RA   Kato S.;
RT   "Cloning and expression of cDNA encoding a human ubiquitin-conjugating
RT   enzyme similar to the Drosophila bendless gene product.";
RL   J. Biochem. 120:494-497(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 15-24; 34-68; 86-92 AND 95-102, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 86-94, MUTAGENESIS OF LYS-92, ISGYLATION AT
RP   LYS-92, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16122702; DOI=10.1016/j.bbrc.2005.08.038;
RA   Zou W., Papov V., Malakhova O., Kim K.I., Dao C., Li J., Zhang D.-E.;
RT   "ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form
RT   thioester bond with ubiquitin.";
RL   Biochem. Biophys. Res. Commun. 336:61-68(2005).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH UBE2V2.
RX   PubMed=10089880; DOI=10.1016/S0092-8674(00)80575-9;
RA   Hofmann R.M., Pickart C.M.;
RT   "Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in
RT   assembly of novel polyubiquitin chains for DNA repair.";
RL   Cell 96:645-653(1999).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH UBE2V2.
RX   PubMed=14562038; DOI=10.1038/sj.onc.1206831;
RA   Bothos J., Summers M.K., Venere M., Scolnick D.M., Halazonetis T.D.;
RT   "The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form
RT   Lys63-linked polyubiquitin chains.";
RL   Oncogene 22:7101-7107(2003).
RN   [8]
RP   MUTAGENESIS OF LYS-92 AND LYS-94, AND ISGYLATION AT LYS-92.
RX   PubMed=16112642; DOI=10.1016/j.bbrc.2005.08.034;
RA   Takeuchi T., Yokosawa H.;
RT   "ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating
RT   activity.";
RL   Biochem. Biophys. Res. Commun. 336:9-13(2005).
RN   [9]
RP   INTERACTION WITH SHPRH, AND MUTAGENESIS OF CYS-87.
RX   PubMed=17130289; DOI=10.1083/jcb.200606145;
RA   Motegi A., Sood R., Moinova H., Markowitz S.D., Liu P.P., Myung K.;
RT   "Human SHPRH suppresses genomic instability through proliferating cell
RT   nuclear antigen polyubiquitination.";
RL   J. Cell Biol. 175:703-708(2006).
RN   [10]
RP   INTERACTION WITH RNF8.
RX   PubMed=16215985; DOI=10.1002/jcb.20587;
RA   Plans V., Scheper J., Soler M., Loukili N., Okano Y., Thomson T.M.;
RT   "The RING finger protein RNF8 recruits UBC13 for lysine 63-based self
RT   polyubiquitylation.";
RL   J. Cell. Biochem. 97:572-582(2006).
RN   [11]
RP   INTERACTION WITH SHPRH.
RX   PubMed=17108083; DOI=10.1073/pnas.0608595103;
RA   Unk I., Hajdu I., Fatyol K., Szakal B., Blastyak A., Bermudez V.,
RA   Hurwitz J., Prakash L., Prakash S., Haracska L.;
RT   "Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent
RT   polyubiquitylation of proliferating cell nuclear antigen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:18107-18112(2006).
RN   [12]
RP   MUTAGENESIS OF CYS-87.
RX   PubMed=17135271; DOI=10.1074/jbc.M609503200;
RA   Lamothe B., Besse A., Campos A.D., Webster W.K., Wu H., Darnay B.G.;
RT   "Site-specific Lys-63-linked tumor necrosis factor receptor-associated
RT   factor 6 auto-ubiquitination is a critical determinant of I kappa B
RT   kinase activation.";
RL   J. Biol. Chem. 282:4102-4112(2007).
RN   [13]
RP   INTERACTION WITH HLTF.
RX   PubMed=18316726; DOI=10.1073/pnas.0800563105;
RA   Unk I., Hajdu I., Fatyol K., Hurwitz J., Yoon J.-H., Prakash L.,
RA   Prakash S., Haracska L.;
RT   "Human HLTF functions as a ubiquitin ligase for proliferating cell
RT   nuclear antigen polyubiquitination.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3768-3773(2008).
RN   [14]
RP   INTERACTION WITH HLTF.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X.,
RA   Moinova H., Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and
RT   SHPRH prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [15]
RP   INTERACTION WITH RNF168.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M.,
RA   Oldreive C., Wildenhain J., Tagliaferro A., Pelletier L.,
RA   Taubenheim N., Durandy A., Byrd P.J., Stankovic T., Taylor A.M.R.,
RA   Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [16]
RP   FUNCTION IN UBIQUITINATION OF JKAMP.
RX   PubMed=19269966; DOI=10.1074/jbc.M808222200;
RA   Tcherpakov M., Delaunay A., Toth J., Kadoya T., Petroski M.D.,
RA   Ronai Z.A.;
RT   "Regulation of endoplasmic reticulum-associated degradation by RNF5-
RT   dependent ubiquitination of JNK-associated membrane protein (JAMP).";
RL   J. Biol. Chem. 284:12099-12109(2009).
RN   [17]
RP   INTERACTION WITH ARIH2, AND SUBCELLULAR LOCATION.
RX   PubMed=19340006; DOI=10.1038/leu.2009.57;
RA   Marteijn J.A., van der Meer L.T., Smit J.J., Noordermeer S.M.,
RA   Wissink W., Jansen P., Swarts H.G., Hibbert R.G., de Witte T.,
RA   Sixma T.K., Jansen J.H., van der Reijden B.A.;
RT   "The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and
RT   Ubc13 interacting domains.";
RL   Leukemia 23:1480-1489(2009).
RN   [18]
RP   INTERACTION WITH RNF11.
RX   PubMed=18615712; DOI=10.1002/prot.22120;
RA   Scheper J., Oliva B., Villa-Freixa J., Thomson T.M.;
RT   "Analysis of electrostatic contributions to the selectivity of
RT   interactions between RING-finger domains and ubiquitin-conjugating
RT   enzymes.";
RL   Proteins 74:92-103(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-82, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20061386; DOI=10.1074/jbc.M109.089003;
RA   David Y., Ziv T., Admon A., Navon A.;
RT   "The E2 ubiquitin-conjugating enzymes direct polyubiquitination to
RT   preferred lysines.";
RL   J. Biol. Chem. 285:8595-8604(2010).
RN   [21]
RP   ENZYME REGULATION, AND INTERACTION WITH OTUB1.
RX   PubMed=20725033; DOI=10.1038/nature09297;
RA   Nakada S., Tai I., Panier S., Al-Hakim A., Iemura S., Juang Y.C.,
RA   O'Donnell L., Kumakubo A., Munro M., Sicheri F., Gingras A.C.,
RA   Natsume T., Suda T., Durocher D.;
RT   "Non-canonical inhibition of DNA damage-dependent ubiquitination by
RT   OTUB1.";
RL   Nature 466:941-946(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   FUNCTION.
RX   PubMed=21512573; DOI=10.1038/nature09976;
RA   Pertel T., Hausmann S., Morger D., Zueger S., Guerra J., Lascano J.,
RA   Reinhard C., Santoni F.A., Uchil P.D., Chatel L., Bisiaux A.,
RA   Albert M.L., Strambio-De-Castillia C., Mothes W., Pizzato M.,
RA   Gruetter M.G., Luban J.;
RT   "TRIM5 is an innate immune sensor for the retrovirus capsid lattice.";
RL   Nature 472:361-365(2011).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=21659603; DOI=10.1126/science.1203430;
RA   Cotta-Ramusino C., McDonald E.R. III, Hurov K., Sowa M.E.,
RA   Harper J.W., Elledge S.J.;
RT   "A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1
RT   interacting protein required for ATR signaling.";
RL   Science 332:1313-1317(2011).
RN   [25]
RP   ISGYLATION, AND DISULFIDE BOND.
RX   PubMed=22693631; DOI=10.1371/journal.pone.0038294;
RA   Bade V.N., Nickels J., Keusekotten K., Praefcke G.J.;
RT   "Covalent protein modification with ISG15 via a conserved cysteine in
RT   the hinge region.";
RL   PLoS ONE 7:E38294-E38294(2012).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH UBE2V2.
RX   PubMed=11473255; DOI=10.1038/90373;
RA   Moraes T.F., Edwards R.A., McKenna S., Pastushok L., Xiao W.,
RA   Glover J.N.M., Ellison M.J.;
RT   "Crystal structure of the human ubiquitin conjugating enzyme complex,
RT   hMms2-hUbc13.";
RL   Nat. Struct. Biol. 8:669-673(2001).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 2-152 IN COMPLEX WITH STUB1
RP   AND UBE2V1.
RX   PubMed=16307917; DOI=10.1016/j.molcel.2005.09.023;
RA   Zhang M., Windheim M., Roe S.M., Peggie M., Cohen P., Prodromou C.,
RA   Pearl L.H.;
RT   "Chaperoned ubiquitylation -- crystal structures of the CHIP U box E3
RT   ubiquitin ligase and a CHIP-Ubc13-Uev1a complex.";
RL   Mol. Cell 20:525-538(2005).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (4.8 ANGSTROMS) OF 1-150 IN COMPLEX WITH RNF8
RP   AND UBE2V2.
RX   PubMed=22589545; DOI=10.1074/jbc.M112.359653;
RA   Campbell S.J., Edwards R.A., Leung C.C., Neculai D., Hodge C.D.,
RA   Dhe-Paganon S., Glover J.N.;
RT   "Molecular insights into the function of RING Finger (RNF)-containing
RT   proteins hRNF8 and hRNF168 in Ubc13/Mms2-dependent ubiquitylation.";
RL   J. Biol. Chem. 287:23900-23910(2012).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-271 IN COMPLEX WITH UBE2V2
RP   AND OTUB1, ENZYME REGULATION, AND INTERACTION WITH OTUB1.
RX   PubMed=22325355; DOI=10.1016/j.molcel.2012.01.011;
RA   Juang Y.C., Landry M.C., Sanches M., Vittal V., Leung C.C.,
RA   Ceccarelli D.F., Mateo A.R., Pruneda J.N., Mao D.Y., Szilard R.K.,
RA   Orlicky S., Munro M., Brzovic P.S., Klevit R.E., Sicheri F.,
RA   Durocher D.;
RT   "OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2
RT   enzyme function.";
RL   Mol. Cell 45:384-397(2012).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (3.11 ANGSTROMS) IN COMPLEX WITH OUTB1 AND
RP   UBIQUITIN, ENZYME REGULATION, AND INTERACTION WITH OTUB1.
RX   PubMed=22367539; DOI=10.1038/nature10911;
RA   Wiener R., Zhang X., Wang T., Wolberger C.;
RT   "The mechanism of OTUB1-mediated inhibition of ubiquitination.";
RL   Nature 483:618-622(2012).
CC   -!- FUNCTION: The UBE2V1-UBE2N and UBE2V2-UBE2N heterodimers catalyze
CC       the synthesis of non-canonical 'Lys-63'-linked polyubiquitin
CC       chains. This type of polyubiquitination does not lead to protein
CC       degradation by the proteasome. Mediates transcriptional activation
CC       of target genes. Plays a role in the control of progress through
CC       the cell cycle and differentiation. Plays a role in the error-free
CC       DNA repair pathway and contributes to the survival of cells after
CC       DNA damage. Acts together with the E3 ligases, HLTF and SHPRH, in
CC       the 'Lys-63'-linked poly-ubiquitination of PCNA upon genotoxic
CC       stress, which is required for DNA repair. Appears to act together
CC       with E3 ligase RNF5 in the 'Lys-63'-linked polyubiquitination of
CC       JKAMP thereby regulating JKAMP function by decreasing its
CC       association with components of the proteasome and ERAD. Promotes
CC       TRIM5 capsid-specific restriction activity and the UBE2V1-UBE2N
CC       heterodimer acts in concert with TRIM5 to generate 'Lys-63'-linked
CC       polyubiquitin chains which activate the MAP3K7/TAK1 complex which
CC       in turn results in the induction and expression of NF-kappa-B and
CC       MAPK-responsive inflammatory genes. {ECO:0000269|PubMed:10089880,
CC       ECO:0000269|PubMed:14562038, ECO:0000269|PubMed:19269966,
CC       ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:21512573}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine
CC       = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2
CC       ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-
CC       ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133,
CC       ECO:0000269|PubMed:20061386}.
CC   -!- ENZYME REGULATION: Activity is inhibited by binding to OTUB1,
CC       which prevents 'Lys-63'-linked polyubiquitination.
CC       {ECO:0000269|PubMed:20725033, ECO:0000269|PubMed:22325355,
CC       ECO:0000269|PubMed:22367539}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Heterodimer with UBE2V2. Interacts (UBE2V2-UBE2N
CC       heterodimer) with the E3 ligase STUB1 (via the U-box domain); the
CC       complex has a specific 'Lys-63'-linked polyubiquitination
CC       activity. Interacts with RNF8 and RNF168. Interacts with RNF11.
CC       Interacts with the E3 ligases, HLTF and SHPRH; the interactions
CC       promote the 'Lys-63'-linked polyubiquitination of PCNA upon
CC       genotoxic stress and lead to DNA repair. Interacts with ARIH2 (via
CC       RING-type 2). Interacts with OTUB1; leading to inhibit E2-
CC       conjugating activity. {ECO:0000269|PubMed:10089880,
CC       ECO:0000269|PubMed:11473255, ECO:0000269|PubMed:14562038,
CC       ECO:0000269|PubMed:16215985, ECO:0000269|PubMed:16307917,
CC       ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:17130289,
CC       ECO:0000269|PubMed:18316726, ECO:0000269|PubMed:18615712,
CC       ECO:0000269|PubMed:18719106, ECO:0000269|PubMed:19203578,
CC       ECO:0000269|PubMed:19340006, ECO:0000269|PubMed:20725033,
CC       ECO:0000269|PubMed:22325355, ECO:0000269|PubMed:22367539,
CC       ECO:0000269|PubMed:22589545}.
CC   -!- INTERACTION:
CC       Q13489:BIRC3; NbExp=2; IntAct=EBI-1052908, EBI-517709;
CC       Q6UWE0:LRSAM1; NbExp=3; IntAct=EBI-1052908, EBI-720984;
CC       Q62925:Map3k1 (xeno); NbExp=44; IntAct=EBI-1052908, EBI-636664;
CC       Q9BYM8:RBCK1; NbExp=2; IntAct=EBI-1052908, EBI-2340624;
CC       Q6PCD5:RFWD3; NbExp=2; IntAct=EBI-1052908, EBI-2129159;
CC       Q9Y3C5:RNF11; NbExp=4; IntAct=EBI-1052908, EBI-396669;
CC       O43567:RNF13; NbExp=2; IntAct=EBI-1052908, EBI-2129183;
CC       Q8IYW5:RNF168; NbExp=2; IntAct=EBI-1052908, EBI-914207;
CC       Q8N6D2:RNF182; NbExp=2; IntAct=EBI-1052908, EBI-2130099;
CC       Q9UNE7:STUB1; NbExp=5; IntAct=EBI-1052908, EBI-357085;
CC       Q9WUD1:Stub1 (xeno); NbExp=2; IntAct=EBI-1052908, EBI-773027;
CC       Q9Y4K3:TRAF6; NbExp=4; IntAct=EBI-1052908, EBI-359276;
CC       Q13049:TRIM32; NbExp=3; IntAct=EBI-1052908, EBI-742790;
CC       Q13404:UBE2V1; NbExp=18; IntAct=EBI-1052908, EBI-1050671;
CC       Q15819:UBE2V2; NbExp=4; IntAct=EBI-1052908, EBI-714329;
CC       P98170:XIAP; NbExp=2; IntAct=EBI-1052908, EBI-517127;
CC       Q8ND25:ZNRF1; NbExp=4; IntAct=EBI-1052908, EBI-2129250;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19340006}.
CC       Cytoplasm {ECO:0000269|PubMed:19340006}.
CC   -!- PTM: Conjugation to ISG15 impairs formation of the thioester bond
CC       with ubiquitin but not interaction with UBE2V2.
CC       {ECO:0000269|PubMed:16112642}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D83004; BAA11675.1; -; mRNA.
DR   EMBL; BT006873; AAP35519.1; -; mRNA.
DR   EMBL; BC000396; AAH00396.1; -; mRNA.
DR   EMBL; BC003365; AAH03365.1; -; mRNA.
DR   EMBL; BC108704; AAI08705.1; -; mRNA.
DR   CCDS; CCDS31875.1; -.
DR   PIR; JC4894; JC4894.
DR   RefSeq; NP_003339.1; NM_003348.3.
DR   UniGene; Hs.524630; -.
DR   PDB; 1J7D; X-ray; 1.85 A; B=1-152.
DR   PDB; 2C2V; X-ray; 2.90 A; B/E/H/K=2-152.
DR   PDB; 3HCT; X-ray; 2.10 A; B=1-152.
DR   PDB; 3HCU; X-ray; 2.60 A; B/D=1-152.
DR   PDB; 3VON; X-ray; 3.15 A; C/E/G/J/L/N/Q/S/U/X/Z/b/e/g/i/l/n/p=3-150.
DR   PDB; 3W31; X-ray; 2.96 A; B=1-152.
DR   PDB; 4DHI; X-ray; 1.80 A; D=1-152.
DR   PDB; 4DHJ; X-ray; 2.35 A; C/G/K/N=1-152.
DR   PDB; 4DHZ; X-ray; 3.11 A; F=1-152.
DR   PDB; 4IP3; X-ray; 2.30 A; B=1-152.
DR   PDB; 4NR3; X-ray; 1.80 A; B=2-150.
DR   PDB; 4NRG; X-ray; 1.95 A; B=1-152.
DR   PDB; 4NRI; X-ray; 2.30 A; B=3-150.
DR   PDB; 4ONL; X-ray; 1.35 A; B=1-152.
DR   PDB; 4ONM; X-ray; 1.35 A; B=1-152.
DR   PDB; 4ONN; X-ray; 1.50 A; B=1-152.
DR   PDB; 4ORH; X-ray; 4.80 A; B/F/J=1-152.
DR   PDB; 4TKP; X-ray; 2.08 A; A=2-152.
DR   PDB; 4WHV; X-ray; 8.30 A; B/E/H/K=1-152.
DR   PDB; 5AIT; X-ray; 3.40 A; B/E=1-152.
DR   PDB; 5AIU; X-ray; 2.21 A; B/E=1-152.
DR   PDB; 5EYA; X-ray; 2.40 A; A/B=1-152.
DR   PDBsum; 1J7D; -.
DR   PDBsum; 2C2V; -.
DR   PDBsum; 3HCT; -.
DR   PDBsum; 3HCU; -.
DR   PDBsum; 3VON; -.
DR   PDBsum; 3W31; -.
DR   PDBsum; 4DHI; -.
DR   PDBsum; 4DHJ; -.
DR   PDBsum; 4DHZ; -.
DR   PDBsum; 4IP3; -.
DR   PDBsum; 4NR3; -.
DR   PDBsum; 4NRG; -.
DR   PDBsum; 4NRI; -.
DR   PDBsum; 4ONL; -.
DR   PDBsum; 4ONM; -.
DR   PDBsum; 4ONN; -.
DR   PDBsum; 4ORH; -.
DR   PDBsum; 4TKP; -.
DR   PDBsum; 4WHV; -.
DR   PDBsum; 5AIT; -.
DR   PDBsum; 5AIU; -.
DR   PDBsum; 5EYA; -.
DR   ProteinModelPortal; P61088; -.
DR   SMR; P61088; -.
DR   BioGrid; 113182; 164.
DR   DIP; DIP-29829N; -.
DR   IntAct; P61088; 134.
DR   MINT; MINT-5001139; -.
DR   STRING; 9606.ENSP00000316176; -.
DR   BindingDB; P61088; -.
DR   ChEMBL; CHEMBL6089; -.
DR   iPTMnet; P61088; -.
DR   PhosphoSitePlus; P61088; -.
DR   SwissPalm; P61088; -.
DR   BioMuta; UBE2N; -.
DR   DMDM; 46577660; -.
DR   OGP; Q16781; -.
DR   REPRODUCTION-2DPAGE; IPI00003949; -.
DR   EPD; P61088; -.
DR   PaxDb; P61088; -.
DR   PeptideAtlas; P61088; -.
DR   PRIDE; P61088; -.
DR   TopDownProteomics; P61088; -.
DR   DNASU; 7334; -.
DR   Ensembl; ENST00000318066; ENSP00000316176; ENSG00000177889.
DR   GeneID; 7334; -.
DR   KEGG; hsa:7334; -.
DR   CTD; 7334; -.
DR   DisGeNET; 7334; -.
DR   GeneCards; UBE2N; -.
DR   HGNC; HGNC:12492; UBE2N.
DR   HPA; HPA044976; -.
DR   MalaCards; UBE2N; -.
DR   MIM; 603679; gene.
DR   neXtProt; NX_P61088; -.
DR   OpenTargets; ENSG00000177889; -.
DR   PharmGKB; PA37141; -.
DR   eggNOG; KOG0417; Eukaryota.
DR   eggNOG; COG5078; LUCA.
DR   GeneTree; ENSGT00540000070023; -.
DR   HOGENOM; HOG000233455; -.
DR   HOVERGEN; HBG063308; -.
DR   InParanoid; P61088; -.
DR   KO; K10580; -.
DR   OMA; IDKWSPA; -.
DR   PhylomeDB; P61088; -.
DR   TreeFam; TF101126; -.
DR   BRENDA; 2.3.2.B6; 2681.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-445989; TAK1 activates NFkB by phosphorylation and activation of IKKs complex.
DR   Reactome; R-HSA-446652; Interleukin-1 signaling.
DR   Reactome; R-HSA-450302; activated TAK1 mediates p38 MAPK activation.
DR   Reactome; R-HSA-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-937039; IRAK1 recruits IKK complex.
DR   Reactome; R-HSA-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-HSA-975110; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling.
DR   Reactome; R-HSA-975144; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P61088; -.
DR   SIGNOR; P61088; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2N; human.
DR   EvolutionaryTrace; P61088; -.
DR   GeneWiki; UBE2N; -.
DR   GenomeRNAi; 7334; -.
DR   PRO; PR:P61088; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000177889; -.
DR   CleanEx; HS_UBE2N; -.
DR   ExpressionAtlas; P61088; baseline and differential.
DR   Genevisible; P61088; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0031372; C:UBC13-MMS2 complex; IDA:HGNC.
DR   GO; GO:0035370; C:UBC13-UEV1A complex; IDA:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; IDA:HGNC.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0000187; P:activation of MAPK activity; TAS:Reactome.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0000729; P:DNA double-strand break processing; IMP:HGNC.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:HGNC.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070911; P:global genome nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0016574; P:histone ubiquitination; IMP:HGNC.
DR   GO; GO:0007254; P:JNK cascade; TAS:Reactome.
DR   GO; GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IMP:HGNC.
DR   GO; GO:0031058; P:positive regulation of histone modification; IMP:HGNC.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:HGNC.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein transferase activity; IMP:HGNC.
DR   GO; GO:0006301; P:postreplication repair; IMP:HGNC.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IMP:HGNC.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   GO; GO:0006282; P:regulation of DNA repair; TAS:ProtInc.
DR   GO; GO:0033182; P:regulation of histone ubiquitination; IMP:HGNC.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR023313; UBQ-conjugating_AS.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS00183; UBIQUITIN_CONJUGAT_1; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; DNA damage; DNA repair;
KW   Isopeptide bond; Nucleotide-binding; Nucleus; Reference proteome;
KW   Transferase; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN         1    152       Ubiquitin-conjugating enzyme E2 N.
FT                                /FTId=PRO_0000082502.
FT   ACT_SITE     87     87       Glycyl thioester intermediate.
FT   MOD_RES      82     82       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   DISULFID     87     87       Interchain (with C-78 in ISG15).
FT                                {ECO:0000269|PubMed:22693631}.
FT   CROSSLNK     92     92       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ISG15).
FT                                {ECO:0000269|PubMed:16112642,
FT                                ECO:0000269|PubMed:16122702}.
FT   MUTAGEN      87     87       C->A: Loss of polyubiquitination of PCNA.
FT                                Impairs interaction with SHPRH.
FT                                {ECO:0000269|PubMed:17130289,
FT                                ECO:0000269|PubMed:17135271}.
FT   MUTAGEN      92     92       K->R: No ISGylation.
FT                                {ECO:0000269|PubMed:16112642,
FT                                ECO:0000269|PubMed:16122702}.
FT   MUTAGEN      94     94       K->R: No effect on ISGylation.
FT                                {ECO:0000269|PubMed:16112642}.
FT   HELIX         6     17       {ECO:0000244|PDB:4ONL}.
FT   STRAND       23     27       {ECO:0000244|PDB:4ONL}.
FT   STRAND       34     40       {ECO:0000244|PDB:4ONL}.
FT   TURN         46     49       {ECO:0000244|PDB:4ONL}.
FT   STRAND       51     57       {ECO:0000244|PDB:4ONL}.
FT   TURN         60     64       {ECO:0000244|PDB:4ONL}.
FT   STRAND       68     71       {ECO:0000244|PDB:4ONL}.
FT   STRAND       78     80       {ECO:0000244|PDB:5AIT}.
FT   HELIX        89     91       {ECO:0000244|PDB:4ONL}.
FT   TURN         92     94       {ECO:0000244|PDB:4ONM}.
FT   HELIX       101    113       {ECO:0000244|PDB:4ONL}.
FT   STRAND      121    123       {ECO:0000244|PDB:4ONL}.
FT   HELIX       124    131       {ECO:0000244|PDB:4ONL}.
FT   HELIX       133    147       {ECO:0000244|PDB:4ONL}.
FT   STRAND      148    150       {ECO:0000244|PDB:4DHI}.
SQ   SEQUENCE   152 AA;  17138 MW;  FACD84D883D77407 CRC64;
     MAGLPRRIIK ETQRLLAEPV PGIKAEPDES NARYFHVVIA GPQDSPFEGG TFKLELFLPE
     EYPMAAPKVR FMTKIYHPNV DKLGRICLDI LKDKWSPALQ IRTVLLSIQA LLSAPNPDDP
     LANDVAEQWK TNEAQAIETA RAWTRLYAMN NI
//
